Prof. Dr. med. Ahmad Amanzada
Oberarzt
Leitender Oberarzt und stellvertretender Direktor der Klinik für Gastroenterologie, gastrointestinale Onkologie und Endokrinologie
Sektionsleiter Interventionelle onkologische Endoskopie
Bereichsleiter Klinische Infektiologie
Telefon: 0551 3962313
Curriculum Vitae
| Academic Education | |
|---|---|
| 1999 to 2006 | Studies of human medicine at the Georg-August-University, Goettingen, Germany, licence to practice medicine |
| Scientific Degrees | |
|---|---|
| 2003 to 2006 | University Medical Centre Goettingen, Germany Clinic of Gastroenterology and Endocrinology Doctoral Thesis: Expression of Myeloperoxidase in rat and human liver (magna cum laude; in Cooperation with PD Dr. med. Thomas Armbrust) |
| 2006 to 2014 | University Medical Centre Goettingen, Germany Clinic of Gastroenterology and Endocrinology Postdoctoral Lecture Qualification: Predictive Factors for Therapy Outcome in chronic HCV infected Patients |
| Professional Work Experience | |
|---|---|
| Since 03/2016 | Clinic of Gastroenterology and gastrointestinal Oncology, Goettingen, Germany Internist, Gastroenterologist, Research Associate and Senior Physician |
| 2014 to 2016 | Clinic of Gastroenterology and gastrointestinal Oncology, Goettingen, Germany Internist, Gastroenterologist and Research Associate |
| 2012 to 2014 | Clinic of Gastroenterology and Endocrinology, Goettingen, Germany Internist and Research Associate |
| 2010 to 2012 | Clinic of Gastroenterology and Endocrinology, Goettingen, Germany Assistant Physician and Research Associate |
| 2009 to 2010 | Clinic of Cardiology, Hospital of Barmbek, Hamburg, Germany Assistant Physician and Research Associate |
| 2006 to 2009 | Clinic of Gastroenterology and Endocrinology, Goettingen, Germany Assistant Physician and Research Associate |
Additional Information
- Principal investigator in I6T-MC-AMAM Phase III Study (2018-004614-18)
- Subinvestigator in PEG-rIL29 Phase II Study (2009-011786-80)
- Principal investigator in NIS-Roche Study (ML21645/ML25724)
- Subinvestigator in H9H-MC-JBAK, Phase II Study (2010-022338-10)
- Subinvestigator in NIS-Sorint Study (NX1313)
- Editorial Board Member of Digestion (since 2014)
- Peer Reviewer for PLoS one, Journal of Medical Virology and Digestion
3rd party funding (2012-2016)
- Participant in DFG project AM 380/2-1 ‘Molekulare Evolution von Mycobacterium avium subsp. paratuberculosis in Afrika’
- Participant in DFG project ‘Adhesion molecules and liver inflammation after radiation: Role of PECAM-1’
- Participant in DFG project MI 474/1-1 ‘Importance of genetic polymorphisms for the pharmacological Effects of interferon-α’
- Project leader of ‘Investigation of the cell interaction between neutrophil granulocytes and liver macrophages’ funded within the University Medical Centre, Goettingen)
Memberships
- DGVS (Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten)
- DEGUM (Deutsche Gesellschaft für Ultraschall in der Medizin)
- NDGG (Norddeutsche Gesellschaft für Gastroenterologie e.V.)
- Kompetenznetz Darmerkrankungen e. V.